The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

We view Cigna's pharmaceutical benefit management business (bolstered through the Express Scripts merger and now called Evernorth) as competitively advantaged in its own right. With the top three ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma ...

The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

Evoke Pharma reports positive results for a study on GIMOTI. Evoke Pharma stock has now tripled since early September.

The Pharma & Biotech market had a relatively muted month. There were a number of companies that experienced strong share ...

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

NTU Singapore is introducing two new undergraduate degree programmes in robotics and advanced chemical and pharmaceutical manufacturing in August ...